Persistent SARS-CoV-2 infection in SCID rats reflects immune vulnerability of the upper airway and trachea
Kaya Miyazaki, Nozomi Shiwa-Sudo, Naoko Iwata-Yoshikawa, Yusuke Sakai, Kazuto Yoshimi, Tomoji Mashimo, Tadaki Suzuki, Eiichi N. Kodama, Hideki Hasegawa, Noriyo NagataABSTRACT
In immunocompromised patients, persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection carries the risk of prolonged viral shedding and emergence of new variants. To reproduce the key features of persistent SARS-CoV-2 infection and evaluate its transmissibility, mouse-passaged SARS-CoV-2 was administered intranasally to severe combined immunodeficiency (SCID) rats deficient in
IMPORTANCE
Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in immunocompromised individuals promotes viral evolution and ongoing transmission, yet mechanistic studies have been limited by the absence of appropriate animal models. Existing mouse systems do not support longitudinal sampling or evaluate transmission, leaving critical questions unanswered. We established an SCID rat model that enables repeated noninvasive sampling from the same individuals, allowing longitudinal analysis of viral dynamics during prolonged infection. This approach revealed the emergence, disappearance, and fixation of viral mutations over time. Persistently infected rats also retained infectious and transmitted virus to naïve SCID rats, providing experimental evidence that prolonged infection preserves the transmission potential in this model. Persistent viral replication localized to the nasal cavity and trachea may be relevant to the upper-airway persistence reported in some immunocompromised patients. By capturing selected features of persistent SARS-CoV-2 infection under profoundly immunodeficient conditions, this model provides a valuable platform for investigating viral persistence, evolution, and transmission.